Secora Michael
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Secora Michael. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| RXRX | Chief Financial Officer | Tax Withholding | 11,937 | $6.18 | $73,771 | Nov 15, 2024 |
| RXRX | Chief Financial Officer | Sale | 15,000 | $7.64 | $114,600 | Nov 12, 2024 |
| RXRX | Chief Financial Officer | Sale | 15,000 | $6.36 | $95,400 | Oct 9, 2024 |
| RXRX | Chief Financial Officer | Option Exercise | 39,375 | $2.22 | $87,413 | Sep 11, 2024 |
| RXRX | Chief Financial Officer | Tax Withholding | 11,962 | $6.69 | $80,026 | Aug 15, 2024 |
| RXRX | Chief Financial Officer | Sale | 15,000 | $6.35 | $95,250 | Aug 13, 2024 |
| RXRX | Chief Financial Officer | Sale | 15,000 | $7.24 | $108,600 | Jul 9, 2024 |
| RXRX | Chief Financial Officer | Option Exercise | 39,375 | $2.22 | $87,413 | Jun 13, 2024 |
| RXRX | Chief Financial Officer | Tax Withholding | 11,962 | $10.01 | $119,740 | May 15, 2024 |
| RXRX | Chief Financial Officer | Option Exercise | 37,500 | $2.22 | $83,250 | Apr 17, 2024 |
| RXRX | Chief Financial Officer | Option Exercise | 37,500 | $2.22 | $83,250 | Mar 13, 2024 |
| RXRX | Chief Financial Officer | Tax Withholding | 7,172 | $12.43 | $89,148 | Feb 15, 2024 |
| RXRX | Chief Financial Officer | Sale | 1,067 | $10.98 | $11,716 | Feb 13, 2024 |
| RXRX | Chief Financial Officer | Award / Grant | 8,659 | — | — | Feb 9, 2024 |
| RXRX | Chief Financial Officer | Sale | 25,000 | $10.25 | $256,250 | Jan 16, 2024 |
| RXRX | Chief Financial Officer | Option Exercise | 37,500 | $2.22 | $83,250 | Dec 13, 2023 |
| RXRX | Chief Financial Officer | Option Exercise | 37,500 | $2.22 | $83,250 | Nov 14, 2023 |
| RXRX | Chief Financial Officer | Sale | 25,000 | $7.07 | $176,750 | Oct 10, 2023 |
| RXRX | Chief Financial Officer | Sale | 25,000 | $8.69 | $217,250 | Sep 12, 2023 |
| RXRX | Chief Financial Officer | Tax Withholding | 4,727 | $9.19 | $43,441 | Aug 16, 2023 |
| RXRX | Chief Financial Officer | Option Exercise | 37,500 | $2.22 | $83,250 | Jul 19, 2023 |
| RXRX | Chief Financial Officer | Option Exercise | 37,500 | $2.22 | $83,250 | Jun 13, 2023 |
| RXRX | Chief Financial Officer | Tax Withholding | 4,760 | $5.60 | $26,656 | May 15, 2023 |
| RXRX | Chief Financial Officer | Tax Withholding | 1,258 | $8.44 | $10,618 | Feb 15, 2023 |
| RXRX | Chief Financial Officer | Award / Grant | 202,428 | — | — | Feb 1, 2023 |
| RXRX | Chief Financial Officer | Tax Withholding | 1,065 | $11.86 | $12,631 | Nov 15, 2022 |
| RXRX | Chief Financial Officer | Tax Withholding | 1,065 | $12.96 | $13,802 | Aug 15, 2022 |
| RXRX | Chief Financial Officer | Tax Withholding | 1,069 | $5.67 | $6,061 | May 16, 2022 |
| RXRX | Chief Financial Officer | Award / Grant | 1,957 | — | — | Feb 4, 2022 |
| RXRX | Chief Financial Officer | Award / Grant | 1,957 | — | — | Feb 4, 2022 |
| RXRX | Chief Financial Officer | Other | 528,762 | — | — | Apr 20, 2021 |